Paper36922504
Engineered exosomes from different sources for cancer-targeted therapy.
Zhang M and 7 others. Signal Transduct Target Ther, 2023. Cited by 420 papers, by iCite.
Cite this record
ConductScience Library. Engineered exosomes from different sources for cancer-targeted therapy. Papers, record 36922504. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36922504
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Exosomes | Major topic |
| Neoplasms | Major topic |
| Extracellular Vesicles | Major topic |
| Humans | |
| Prospective Studies | |
| Immunotherapy |
Source PubMed
References225
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33995674 | Targeted inhibition of SIRT6 via engineered exosomes impairs tumorigenesis and metastasis in prostate cancer. | Theranostics | 2021 | https://conductscience.org/library/papers/33995674 | PubMed |
| 2 | 24048973 | Near-infrared light-mediated nanoplatforms for cancer thermo-chemotherapy and optical imaging. | Adv Mater | 2013 | https://conductscience.org/library/papers/24048973 | PubMed |
| 3 | 34506976 | Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis. | Acta Biomater | 2021 | https://conductscience.org/library/papers/34506976 | PubMed |
| 4 | 23562828 | Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. | J Biotechnol | 2013 | https://conductscience.org/library/papers/23562828 | PubMed |
| 5 | 35133380 | Engineered mesenchymal stem cell-derived exosomes with high CXCR4 levels for targeted siRNA gene therapy against cancer. | Nanoscale | 2022 | https://conductscience.org/library/papers/35133380 | PubMed |
| 6 | 31843452 | Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy. | Mol Ther | 2020 | https://conductscience.org/library/papers/31843452 | PubMed |
| 7 | 26842674 | Temperature-feedback upconversion nanocomposite for accurate photothermal therapy at facile temperature. | Nat Commun | 2016 | https://conductscience.org/library/papers/26842674 | PubMed |
| 8 | 34626550 | Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trial. | Lancet Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/34626550 | PubMed |
| 9 | 31833519 | Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer. | Nanoscale | 2020 | https://conductscience.org/library/papers/31833519 | PubMed |
| 10 | 34560422 | M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages. | Biomaterials | 2021 | https://conductscience.org/library/papers/34560422 | PubMed |
| 11 | 32456079 | N-Terminal Fatty Acids of NEFMUT Are Required for the CD8+ T-Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles. | Vaccines (Basel) | 2020 | https://conductscience.org/library/papers/32456079 | PubMed |
| 12 | 30066406 | Overcoming the Blood-Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases. | Adv Mater | 2018 | https://conductscience.org/library/papers/30066406 | PubMed |
| 13 | 24876563 | Current concepts in the diagnosis and management of cytokine release syndrome. | Blood | 2014 | https://conductscience.org/library/papers/24876563 | PubMed |
| 14 | 33644993 | Engineered Microglia Potentiate the Action of Drugs against Glioma Through Extracellular Vesicles and Tunneling Nanotubes. | Adv Healthc Mater | 2021 | https://conductscience.org/library/papers/33644993 | PubMed |
| 15 | 30312907 | Mitochondria and plasma membrane dual-targeted chimeric peptide for single-agent synergistic photodynamic therapy. | Biomaterials | 2019 | https://conductscience.org/library/papers/30312907 | PubMed |
| 16 | 32929225 | Single-cell multiomics: technologies and data analysis methods. | Exp Mol Med | 2020 | https://conductscience.org/library/papers/32929225 | PubMed |
| 17 | 23111789 | Microfluidic filtration system to isolate extracellular vesicles from blood. | Lab Chip | 2012 | https://conductscience.org/library/papers/23111789 | PubMed |
| 18 | 29144989 | Cysteine Dioxygenase 1 Mediates Erastin-Induced Ferroptosis in Human Gastric Cancer Cells. | Neoplasia | 2017 | https://conductscience.org/library/papers/29144989 | PubMed |
| 19 | 24331707 | Rose-bengal-conjugated gold nanorods for in vivo photodynamic and photothermal oral cancer therapies. | Biomaterials | 2014 | https://conductscience.org/library/papers/24331707 | PubMed |
| 20 | 35600651 | Synergistic strategy with hyperthermia therapy based immunotherapy and engineered exosomes-liposomes targeted chemotherapy prevents tumor recurrence and metastasis in advanced breast cancer. | Bioeng Transl Med | 2022 | https://conductscience.org/library/papers/35600651 | PubMed |
Cited by303
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 420 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42964617 | Hydrogel-based delivery of extracellular vesicles for skin wound healing: design strategies, therapeutic mechanisms, and translational perspectives. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/42964617 | PubMed |
| 42953413 | The Current Landscape of Exosome-Based Strategies for Breast Cancer Brain Metastasis: From Mechanistic Insights to Therapeutic Potential. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42953413 | PubMed |
| 42902378 | HAMA microneedles patch loaded with muscle-targeting engineered apoptotic vesicles and attenuating sarcopenia by regulating mitochondrial homeostasis. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42902378 | PubMed |
| 42882510 | Exosomes and Extracellular Vesicles in Oncology: Next-Generation Smart Nanocarriers for Precision Cancer Therapy. | Cells | 2026 | https://conductscience.org/library/papers/42882510 | PubMed |
| 42866611 | Engineered exosomes for breast cancer immunotherapy: Emerging strategies and translational potential. | Biochem Biophys Rep | 2026 | https://conductscience.org/library/papers/42866611 | PubMed |
| 42860857 | UPLC-Q-TOF-MS/MS Profiling and Synergistic Anti-HCC Activity of Gallic Acid From Compound Muji Granules Combined With hUC-MSC-Exos. | Chem Biodivers | 2026 | https://conductscience.org/library/papers/42860857 | PubMed |
| 42852184 | Advancing Membrane Technologies for Cancer Therapy and Environmental Health: Biomimetic Innovations, Smart Technologies, and Sustainable Translation. | ACS Omega | 2026 | https://conductscience.org/library/papers/42852184 | PubMed |
| 42814771 | Dual-Targeted M1 Macrophage Extracellular Vesicles Reprogram the Tumor Microenvironment and Enhance Natural Killer Cell Immunotherapy in Breast Cancer. | J Extracell Vesicles | 2026 | https://conductscience.org/library/papers/42814771 | PubMed |
| 42797323 | Nanocarrier Systems for Plant-Derived Bioactives: Design, Biosafety, and Translational Challenges. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42797323 | PubMed |
| 42787674 | Synergistic integration of exosomes and natural compounds in 3D-printed bioscaffolds: Revolutionizing diabetic wound healing through multifunctional therapeutic platforms. | Iran J Basic Med Sci | 2026 | https://conductscience.org/library/papers/42787674 | PubMed |
| 42783392 | Extracellular Vesicles at the Interface of Cancer Therapy and Regenerative Medicine: Biology, Bidirectional Roles, and Engineered Therapeutics. | Med Sci (Basel) | 2026 | https://conductscience.org/library/papers/42783392 | PubMed |
| 42771518 | Bioengineered extracellular vesicles integrating anti-EphA2 recognition and oxaliplatin delivery for pancreatic cancer therapy. | Drug Deliv | 2026 | https://conductscience.org/library/papers/42771518 | PubMed |
| 42751176 | Gift of nature: non-human-derived exosomes showing application prospects in periodontitis treatment. | Front Immunol | 2026 | https://conductscience.org/library/papers/42751176 | PubMed |
| 42750825 | Extracellular vesicle-based therapeutic strategies for spinal tumors and associated nerve damage: advances, challenges, and future directions. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42750825 | PubMed |
| 42738821 | A Proposed Microneedle-Small Extracellular Vesicle System for Localized Adjunctive Treatment of Established Oral Squamous Cell Carcinoma: A Narrative Review and Preclinical Development Perspective. | Cells | 2026 | https://conductscience.org/library/papers/42738821 | PubMed |
| 42711497 | Exosome-Based Drug Delivery Systems in Colorectal Cancer: Current Evidence and Future Perspectives. | AAPS J | 2026 | https://conductscience.org/library/papers/42711497 | PubMed |
| 42703176 | An Insight into the Emerging Role of Extracellular Vesicle-derived Noncoding RNAs in Colorectal Cancer. | Microrna | 2026 | https://conductscience.org/library/papers/42703176 | PubMed |
| 42667089 | Organization from cell to tissue derived delivery systems for immunotherapy. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42667089 | PubMed |
| 42609549 | RNA-based approaches in the diagnosis and treatment of obesity. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42609549 | PubMed |
| 42589633 | Exosomes as Emerging Therapeutic and Diagnostic Platforms: Biological Functions, Clinical Applications, and Translational Challenges. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589633 | PubMed |
Genes59
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36922504
GET https://conductscience.org/api/papers/v1/36922504/references?page=2